ComtecMed Medical Congresses is pleased to announce and invite you to participate in The 5th World Congress on Controversies in Ophthalmology (COPHy), which will take place at the Epic Sana Lisboa Hotel in Lisbon, Portugal on March 20 – 23, 2014.
The great success of the previous four COPHy Congresses, held in Prague, Barcelona, Istanbul, Budapest and the enthusiastic feedback from the latest congress illustrated the need for this dynamic congress. We are excited to disclose that COPHy Lisbon will be devoted to evidence-based debates and discussions amongst chairpersons, speakers and the audience, all of whom will examine and analyze the most relevant issues raised during the course of 2013 within the field of ophthalmology.
This educational congress will continue to focus on Anterior Segment, Glaucoma, and Retina sections, and will discuss controversies in other areas of ophthalmology, such as neuro-ophthalmology, as well.
The scientific program will include overviews, state of the art lectures and controversial debates. Outstanding world leaders as faculty will present both pro and con positions while further challenging and exploring the optimal treatment for patients, with emphasis on the appropriate use of new and emerging drugs. This format includes a substantial allocation of time for interactive debates and questions from the audience to each panel of experts. Participants are encouraged to take an active role in the discussions with faculty members which follow each debate, in a unique and open environment.
- Age-related macular degeneration: Nutritional supplements, Aspirin, Drug of choice, Frequency of treatment;
- Behcet’s disease treatment
- Choroidal imaging: Is it necessary for diagnosis, prognosis, or treatment?
- Diabetic macular edema: Drug of choice and treatment regimen with center-involved edema and vision impairment in phakic patients
- DME – Treatment regimen in pseudo phakic patients
- Endophthalmitis prevention in intravitreal injections
- Autofluorescence: Is it necessary for diagnosis, prognosis, or treatment management?
- Laser in DME
- Dietary supplements for age-related macular degeneration
- Multifocal ERG: Is it necessary for diagnosis, prognosis, or treatment
- Retinitis pigmentosa: Current clinical management and future treatments
- Management of Pseudophakic cystoid macular edema
- Retinal vein occlusion with macular edema
- Retinopathy of prematurity
- Uveitis-related cystoid macular edema
- CNV in inflammatory disease
- Choroidal melanoma
- Intraocular lymphoma: Trends in therapy
- Pseudotumor cerebri: Management
- Psuedotumor cerebri in pregnancy
- Pediatric pseudotumor cerebri
- Posterior optic neuropathy: Evaluation and management
- Management of isolated optic neuritis
- Brachytherapy for age-related macular degeneration Choroidal detachment post glaucoma surgery: Management
- Dyes in epiretinal membrane surgery
- Vitreomacular traction
- Macular holes
- Management of macular schisis in pathologic myopia: Surgery or observation?
- Large submacular hemorrhage in predominantly hemorrhagic CNV lesion
- Non-clearing vitreous hemorrhage: When to treat in:
- Vitrectomy for epiretinal membranes
- Anterior Segment
- Femtosecond laser in cataract surgery
- Astigmatism correction: In low pre-op astigmatism
- How to correct low astigmatism?
- Toric IOLs
- Challenging cataract cases
- Dislocated IOL’s
- Dry eye
- IOL Calculations
- LASIK in 2013 – 2014
- Multifocal /accommodative lenses
- Special IOLs
- Phaco fluidics and power settings, technologies, machines
- Penetrating Keratoplasty
- Pupillary dilation
- Premium IOL’s
- Pseudophakic presbyopia solution /general presbyopia correction
- Laser to trabecular meshwork
- Blood flow and perfusion pressure in glaucoma ciliary body ablative procedures
- Coexisting cataract and glaucoma medical management: First line for open angle glaucoma
- Treatment monitoring
- Future of glaucoma treatment
- Future of glaucoma surgery
- Neovascular glaucoma
- Non-penetrating sclerectomy
- Optic nerve head imaging
- Pediatric glaucoma
Participants who wish to give a presentation at the Congress are requested to submit an abstract for review by the Scientific Committee. The Committee reserves the right to decide on the final form of presentation. Abstracts will be published in the abstract book only on receipt of registration fees in full by February 20, 2014.
When submitting your abstract please note:
- Complete full Contact details of the presenting author(s) .
- Details of affiliations of the author(s): institution, city, country.
- Names of authors, names should be written in “Title Case” with First Name Initial and Last Name Only. For example: First Name: J., Last Name: Smith
- Title of the abstract in CAPITAL LETTERS ONLY.
- Abstracts cannot exceed 250 words and cannot include tables and graphs.